Skip to content

Nuvalent, Inc. NUVL Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Pfizer logo
PfizerPFE
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Exelixis logo
ExelixisEXEL
Incyte logo
IncyteINCY
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s other noncash income (expense)?
Nuvalent, Inc. (NUVL) reported other noncash income (expense) of -$120K in Q1 2026.
How has Nuvalent, Inc.'s other noncash income (expense) changed year-over-year?
Nuvalent, Inc.'s other noncash income (expense) decreased by 275.0% year-over-year, from -$32K to -$120K.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.